CA3108123A1 - Uses of curcuminoid compositions - Google Patents

Uses of curcuminoid compositions Download PDF

Info

Publication number
CA3108123A1
CA3108123A1 CA3108123A CA3108123A CA3108123A1 CA 3108123 A1 CA3108123 A1 CA 3108123A1 CA 3108123 A CA3108123 A CA 3108123A CA 3108123 A CA3108123 A CA 3108123A CA 3108123 A1 CA3108123 A1 CA 3108123A1
Authority
CA
Canada
Prior art keywords
turmipure
ste
nov
phyt
curcuminoids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3108123A
Other languages
English (en)
French (fr)
Inventor
Pascale Elizabeth Renee Fanca-Berthon
Leila Denise FALCAO
Mathieu TENON
Maryline VINAL
Simona BIRTIC
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan France Naturals SAS
Original Assignee
Naturex SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1812776.1A external-priority patent/GB201812776D0/en
Priority claimed from GBGB1902266.4A external-priority patent/GB201902266D0/en
Application filed by Naturex SA filed Critical Naturex SA
Priority to CA3292034A priority Critical patent/CA3292034A1/en
Publication of CA3108123A1 publication Critical patent/CA3108123A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA3108123A 2018-08-06 2019-08-05 Uses of curcuminoid compositions Pending CA3108123A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3292034A CA3292034A1 (en) 2018-08-06 2019-08-05 Uses of curcuminoid compositions

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1812776.1A GB201812776D0 (en) 2018-08-06 2018-08-06 New methods and uses
GB1812776.1 2018-08-06
GBGB1902266.4A GB201902266D0 (en) 2019-02-19 2019-02-19 New methods and uses
GB1902266.4 2019-02-19
PCT/EP2019/071055 WO2020030612A1 (en) 2018-08-06 2019-08-05 Uses of curcuminoid compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA3292034A Division CA3292034A1 (en) 2018-08-06 2019-08-05 Uses of curcuminoid compositions

Publications (1)

Publication Number Publication Date
CA3108123A1 true CA3108123A1 (en) 2020-02-13

Family

ID=67770463

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3108123A Pending CA3108123A1 (en) 2018-08-06 2019-08-05 Uses of curcuminoid compositions
CA3292034A Pending CA3292034A1 (en) 2018-08-06 2019-08-05 Uses of curcuminoid compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA3292034A Pending CA3292034A1 (en) 2018-08-06 2019-08-05 Uses of curcuminoid compositions

Country Status (9)

Country Link
US (3) US12059394B2 (https=)
EP (1) EP3833337A1 (https=)
JP (2) JP2021534105A (https=)
CN (1) CN112566630A (https=)
AU (1) AU2019320488B2 (https=)
BR (1) BR112021001403A2 (https=)
CA (2) CA3108123A1 (https=)
MX (1) MX2021000776A (https=)
WO (1) WO2020030612A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113208109B (zh) * 2021-04-30 2023-08-29 河南中大恒源生物科技股份有限公司 一种高生物利用度水溶姜黄素及其制备方法以及应用
CN113383881B (zh) * 2021-04-30 2023-08-29 河南中大恒源生物科技股份有限公司 一种液体水溶姜黄素及其制备方法以及应用
CN115028886B (zh) * 2022-06-21 2023-11-21 贺州学院 一种用于检测铅离子的双去甲氧基姜黄素显色薄膜、其制备方法和铅离子快速检测方法
WO2024041724A1 (en) * 2022-08-22 2024-02-29 Givaudan Sa Composition comprising curcuminoids, modified starch and/or acacia gum and saponins for use as a medicament

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786775B1 (fr) * 1998-12-04 2001-02-16 Roquette Freres Maltodextrines branchees et leur procede de preparation
JP5448511B2 (ja) * 2008-03-31 2014-03-19 三栄源エフ・エフ・アイ株式会社 ウコン色素組成物及びその調製方法
JP2011130696A (ja) * 2009-12-24 2011-07-07 Nihon Cornstarch Corp マルトデキストリンの製造方法
EP2359702B1 (en) * 2010-01-22 2014-06-04 Symrise AG Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides
WO2012105546A1 (ja) * 2011-01-31 2012-08-09 株式会社シクロケムバイオ 脂溶性物質を含む水溶液の製造方法
DE102011056111B4 (de) * 2011-12-06 2013-08-14 Sensient Colors Europe Gmbh Emulsion
ES2646214T3 (es) 2012-10-16 2017-12-12 DÖHLER GmbH Emulsión
US10674757B2 (en) * 2013-06-21 2020-06-09 Firmenich Sa Preparation of dried particles comprising menthol
US20160151440A1 (en) 2013-08-19 2016-06-02 Aurea Biolabs Private Limited A Novel Composition of Curcumin with Enhanced Bioavailability
US10016363B2 (en) 2014-09-18 2018-07-10 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
JP7128739B2 (ja) * 2016-04-01 2022-08-31 三栄源エフ・エフ・アイ株式会社 固体色素の安定化方法
JP6794190B2 (ja) * 2016-09-01 2020-12-02 株式会社ファンケル キマーゼ阻害用組成物
US20190200660A1 (en) * 2016-09-26 2019-07-04 San-Ei Gen F.F.I., Inc. Curcumin composition
WO2018083677A1 (en) * 2016-11-07 2018-05-11 Akay Flavours & Aromatics Pvt. Ltd. Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof
JP6986345B2 (ja) * 2016-11-18 2021-12-22 ロート製薬株式会社 経口組成物及びその製造方法

Also Published As

Publication number Publication date
MX2021000776A (es) 2021-06-15
JP2021534105A (ja) 2021-12-09
CN112566630A (zh) 2021-03-26
JP2025003947A (ja) 2025-01-14
KR20210041037A (ko) 2021-04-14
BR112021001403A2 (pt) 2021-04-27
AU2019320488B2 (en) 2025-01-23
US20250144048A1 (en) 2025-05-08
US20220280448A1 (en) 2022-09-08
EP3833337A1 (en) 2021-06-16
AU2019320488A1 (en) 2021-02-18
US20240115519A1 (en) 2024-04-11
US12220388B2 (en) 2025-02-11
US12059394B2 (en) 2024-08-13
CA3292034A1 (en) 2026-03-02
WO2020030612A1 (en) 2020-02-13

Similar Documents

Publication Publication Date Title
US12220388B2 (en) Uses of curcuminoid compositions
AU2019320487B2 (en) Curcuminoid compositions
Yu et al. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions
Hu et al. Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle
Priyanka et al. Optimization of processing parameters for the development of Ficus religiosa L. extract loaded solid lipid nanoparticles using central composite design and evaluation of antidiabetic efficacy
AU2011368608B2 (en) A water soluble composition comprising curcumin having enhanced bioavailability and process thereof
CN106727441A (zh) 水溶性纳米缓释功能性辅酶q10微胶囊及其制备方法与应用
WO2013171697A1 (en) Oral composition comprising a low- availability active ingredient, for use as a medicament or a dietary/supplement/nutraceutical
Abhilash et al. Enhanced absorption of curcuminoids and 3-Acetyl-11-keto-β-boswellic acid from fenugreek galactomannan hydrogel beadlets: A natural approach to the co-delivery of lipophilic phytonutrients
Kudupudi et al. Formulation development and characterization of vancomycin hydrochloride colon-targeted tablets using in-situ polyelectrolyte complexation technique
Hundshammer et al. Enhanced metabolic bioavailability of tetrahydrocurcumin after oral supplementation of a γ-cyclodextrin curcumin complex
Papillo et al. In vitro evaluation of gastro-intestinal digestion and colonic biotransformation of curcuminoids considering different formulations and food matrices
V. Ambardekar et al. Enhancement of hepatoprotective efficacy of propolis by fabrication of liposomes, as a platform nano-formulation for multi-component natural medicine
Elfiyani et al. Garlic extract phytosome: preparation and physical stability
KR102957602B1 (ko) 커큐미노이드 조성물의 용도
KR102182453B1 (ko) 진세노사이드 흡수율 증진용 복합체 및 그의 제조 방법
KR20260061431A (ko) 커큐미노이드 조성물의 용도
BR112021001405B1 (pt) Composição de curcuminoide, seu uso, processo para sua preparação, e produtos compreendendo tal composição
Goyal et al. Synthesis and characterization of baicalein-loaded aquasomes: an in vitro and in silico perspective for diabetes mellitus
Gagliardi et al. Hydroxytyrosol-loaded zein nanoparticles: A green formulation for pharma/nutraceutical applications
Burns An investigation of curcumin-loaded nanoparticles to treat pathological hallmarks of Parkinson's disease
EP4329788A1 (en) Compositions
CN106509869A (zh) 磷脂酰胆碱结合碳酸氢钠在制备保肝护肝的食品、保健品或药品中的应用
WO2025153741A1 (en) Pharmaceutical composition comprising curcumin and the preparation thereof

Legal Events

Date Code Title Description
P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT

Effective date: 20240710

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240722

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240722

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240722

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT

Effective date: 20240904

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20241101

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20241101

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20241104

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20241108

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20241108

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20241108

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20241108

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250407

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20250430

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250710

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250730

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250730

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20251016